The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes

Abstract Affection of vascular structures is a known complication in diabetes and prediabetes. Subclinical atherosclerosis begins to develop years before both cardiovascular and cerebrovascular diseases become symptomatic. The aim of this study was to evaluate the relationship between circulating ox...

Full description

Saved in:
Bibliographic Details
Main Authors: Zeki Dogan, Abdulhalim Senyigit, Sinem Durmus, Canan Duvarcı, Remise Gelişgen, Hafize Uzun, Omur Tabak
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-89220-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862324149092352
author Zeki Dogan
Abdulhalim Senyigit
Sinem Durmus
Canan Duvarcı
Remise Gelişgen
Hafize Uzun
Omur Tabak
author_facet Zeki Dogan
Abdulhalim Senyigit
Sinem Durmus
Canan Duvarcı
Remise Gelişgen
Hafize Uzun
Omur Tabak
author_sort Zeki Dogan
collection DOAJ
description Abstract Affection of vascular structures is a known complication in diabetes and prediabetes. Subclinical atherosclerosis begins to develop years before both cardiovascular and cerebrovascular diseases become symptomatic. The aim of this study was to evaluate the relationship between circulating oxidized LDL (oxLDL), soluble lectin-like oxidized LDL (sLOX)-1 and proprotein convertase subtilisin/kexin type 9 (PCSK9) levels and carotid intima-media thickness (CIMT) in patients with prediabetes and T2DM. We recruited 50 T2DM patients with macrovascular complications, 50 T2DM patients with uncomplicated, 50 prediabetes patients, and 50 healthy participants. The common carotid arteries were visualized by high-resolution B-mode carotid artery ultrasonography. Measurement of serum oxLDL, sLOX-1 and PCSK9 levels were assessed by using a commercially available human enzyme-linked immunosorbent assay (ELISA) method. Homeostasis model assessment for insulin resistance (HOMA-IR) was also calculated. Circulating LDL-C, oxLDL, sLOX-1 and PCSK9 levels were significantly higher in T2DM patients with macrovascular complications compared to control group, prediabetes and uncomplicated diabetes. There was significant difference, especially between the controls and the T2DM patients with macrovascular complications. The CIMT increased progressively from control through to T2DM. Both right and left CIMT also showed significant differences between the groups of prediabetes versus uncomplicated diabetes at p < 0.001 showing progressive increase in vascular involvement with progression of disease. There was a positive correlation between PCSK9 levels with LDL-C, oxLDL, sLOX-1, and CIMT. ROC curve analyses showed that PCSK9, as well as oxLDL and LOX-1, was a strong predictor of T2DM with high sensitivity and specificity. In this study, we found that oxLDL, sLOX-1 and PCSK9 levels were significantly associated with carotid intima-media thickness. Our findings suggest that these biomarkers may be used as potential markers for the assessment of cardiovascular risk in patients with prediabetes and type 2 diabetes.
format Article
id doaj-art-9c98ec1b8e7e47b6a710caec60c82e0b
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-9c98ec1b8e7e47b6a710caec60c82e0b2025-02-09T12:35:39ZengNature PortfolioScientific Reports2045-23222025-02-0115111210.1038/s41598-025-89220-9The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetesZeki Dogan0Abdulhalim Senyigit1Sinem Durmus2Canan Duvarcı3Remise Gelişgen4Hafize Uzun5Omur Tabak6Department of Cardiology, Faculty of Medicine, Istanbul Atlas UniversityDepartment of Internal Medicine, Faculty of Medicine, Istanbul Atlas UniversityDepartment of Medical Biochemistry, Faculty of Medicine, Katip Celebi UniversityDepartment of Medical Biochemistry, Cerrahpasa Faculty of Medicine, Istanbul University- CerrahpasaDepartment of Medical Biochemistry, Cerrahpasa Faculty of Medicine, Istanbul University- CerrahpasaDepartment of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas UniversityDepartment of Internal Medicine, Kanuni Sultan Suleyman Training and Research Hospital, Health Sciences UniversityAbstract Affection of vascular structures is a known complication in diabetes and prediabetes. Subclinical atherosclerosis begins to develop years before both cardiovascular and cerebrovascular diseases become symptomatic. The aim of this study was to evaluate the relationship between circulating oxidized LDL (oxLDL), soluble lectin-like oxidized LDL (sLOX)-1 and proprotein convertase subtilisin/kexin type 9 (PCSK9) levels and carotid intima-media thickness (CIMT) in patients with prediabetes and T2DM. We recruited 50 T2DM patients with macrovascular complications, 50 T2DM patients with uncomplicated, 50 prediabetes patients, and 50 healthy participants. The common carotid arteries were visualized by high-resolution B-mode carotid artery ultrasonography. Measurement of serum oxLDL, sLOX-1 and PCSK9 levels were assessed by using a commercially available human enzyme-linked immunosorbent assay (ELISA) method. Homeostasis model assessment for insulin resistance (HOMA-IR) was also calculated. Circulating LDL-C, oxLDL, sLOX-1 and PCSK9 levels were significantly higher in T2DM patients with macrovascular complications compared to control group, prediabetes and uncomplicated diabetes. There was significant difference, especially between the controls and the T2DM patients with macrovascular complications. The CIMT increased progressively from control through to T2DM. Both right and left CIMT also showed significant differences between the groups of prediabetes versus uncomplicated diabetes at p < 0.001 showing progressive increase in vascular involvement with progression of disease. There was a positive correlation between PCSK9 levels with LDL-C, oxLDL, sLOX-1, and CIMT. ROC curve analyses showed that PCSK9, as well as oxLDL and LOX-1, was a strong predictor of T2DM with high sensitivity and specificity. In this study, we found that oxLDL, sLOX-1 and PCSK9 levels were significantly associated with carotid intima-media thickness. Our findings suggest that these biomarkers may be used as potential markers for the assessment of cardiovascular risk in patients with prediabetes and type 2 diabetes.https://doi.org/10.1038/s41598-025-89220-9T2DMPrediabetesCarotid intima-media thicknessoxLDLLOX-1PCSK9
spellingShingle Zeki Dogan
Abdulhalim Senyigit
Sinem Durmus
Canan Duvarcı
Remise Gelişgen
Hafize Uzun
Omur Tabak
The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes
Scientific Reports
T2DM
Prediabetes
Carotid intima-media thickness
oxLDL
LOX-1
PCSK9
title The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes
title_full The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes
title_fullStr The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes
title_full_unstemmed The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes
title_short The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes
title_sort relationship between oxldl slox 1 pcsk9 and carotid intima media thickness in patients with prediabetes and type 2 diabetes
topic T2DM
Prediabetes
Carotid intima-media thickness
oxLDL
LOX-1
PCSK9
url https://doi.org/10.1038/s41598-025-89220-9
work_keys_str_mv AT zekidogan therelationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT abdulhalimsenyigit therelationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT sinemdurmus therelationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT cananduvarcı therelationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT remisegelisgen therelationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT hafizeuzun therelationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT omurtabak therelationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT zekidogan relationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT abdulhalimsenyigit relationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT sinemdurmus relationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT cananduvarcı relationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT remisegelisgen relationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT hafizeuzun relationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes
AT omurtabak relationshipbetweenoxldlslox1pcsk9andcarotidintimamediathicknessinpatientswithprediabetesandtype2diabetes